Agios Pharmac

Forecast & Rating10 analysts currently cover Agios Pharmac, with about 70.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $46.00, about 44.0% upside from the current price of $31.95. Price targets range from $32.00 to $73.00 — a wide spread, showing clear disagreement over just how much Agios Pharmac can rise. Historically, about 52.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Agios Pharmac closely still see room for the stock to rise. Data as of Oct 9, 2026; for reference only and not investment advice.